Literature DB >> 28188404

[Direct oral anticoagulants and acute stroke : Insights into translational research studies].

C Foerch1, J H Schäfer2, W Pfeilschifter2, F Bohmann2.   

Abstract

In recent years a considerable number of translational research studies on intracerebral hemorrhage and ischemic stroke have been published, which are characterized by a particular proximity to practical clinical questions. Animal research has provided insights into the pathophysiological processes and therapy effects, which have so far only been insufficiently investigated in clinical studies. This includes the effectiveness of a rapid reversal of anticoagulation in cases of anticoagulation-associated intracerebral hemorrhage and the safety of thrombolytic treatment in ischemic stroke occurring during treatment with anticoagulants. With the approval of the direct oral anticoagulants these problems have become of particular contemporary relevance. Of course, results from experimental translational studies on stroke cannot be directly translated into clinical routine. Nevertheless, these investigations help to understand the underlying processes and mechanisms and provide proof of concept data for new treatment strategies. This review summarizes the most relevant results in this field of research with a particular focus on practical clinical questions.

Entities:  

Keywords:  Animal model; Experimental research; Intracerebral hemorrhage; Ischemic stroke; Thrombolysis

Mesh:

Substances:

Year:  2017        PMID: 28188404     DOI: 10.1007/s00115-017-0282-6

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  50 in total

1.  Anticoagulation with the oral direct thrombin inhibitor dabigatran does not enlarge hematoma volume in experimental intracerebral hemorrhage.

Authors:  Arne Lauer; Flor A Cianchetti; Elizabeth M Van Cott; Frieder Schlunk; Elena Schulz; Waltraud Pfeilschifter; Helmuth Steinmetz; Chris B Schaffer; Eng H Lo; Christian Foerch
Journal:  Circulation       Date:  2011-09-12       Impact factor: 29.690

Review 2.  Intracerebral hemorrhage associated with oral anticoagulant therapy: current practices and unresolved questions.

Authors:  Thorsten Steiner; Jonathan Rosand; Michael Diringer
Journal:  Stroke       Date:  2005-12-08       Impact factor: 7.914

3.  Recombinant activated coagulation factor VII and prothrombin complex concentrates are equally effective in reducing hematoma volume in experimental warfarin-associated intracerebral hemorrhage.

Authors:  Frieder Schlunk; Elizabeth M Van Cott; Kazuhide Hayakawa; Waltraud Pfeilschifter; Eng H Lo; Christian Foerch
Journal:  Stroke       Date:  2011-10-13       Impact factor: 7.914

4.  Hemostatic therapy in experimental intracerebral hemorrhage associated with the direct thrombin inhibitor dabigatran.

Authors:  Wei Zhou; Sönke Schwarting; Sergio Illanes; Arthur Liesz; Moritz Middelhoff; Markus Zorn; Martin Bendszus; Sabine Heiland; Joanne van Ryn; Roland Veltkamp
Journal:  Stroke       Date:  2011-10-13       Impact factor: 7.914

5.  Activated protein C inhibits tissue plasminogen activator-induced brain hemorrhage.

Authors:  Tong Cheng; Anthony L Petraglia; Zhang Li; Meenakshisundaram Thiyagarajan; Zhihui Zhong; Zhenhua Wu; Dong Liu; Sanjay B Maggirwar; Rashid Deane; José A Fernández; Barbra LaRue; John H Griffin; Michael Chopp; Berislav V Zlokovic
Journal:  Nat Med       Date:  2006-10-29       Impact factor: 53.440

Review 6.  Treatment of warfarin-associated intracerebral hemorrhage: literature review and expert opinion.

Authors:  Maria I Aguilar; Robert G Hart; Carlos S Kase; William D Freeman; Barbara J Hoeben; Rosa C García; Jack E Ansell; Stephan A Mayer; Bo Norrving; Jonathan Rosand; Thorsten Steiner; Eelco F M Wijdicks; Takenori Yamaguchi; Masahiro Yasaka
Journal:  Mayo Clin Proc       Date:  2007-01       Impact factor: 7.616

7.  The middle cerebral artery occlusion model of transient focal cerebral ischemia.

Authors:  Fudong Liu; Louise D McCullough
Journal:  Methods Mol Biol       Date:  2014

8.  Intravenous Thrombolysis after Reversal of Dabigatran by Idarucizumab: A Case Report.

Authors:  Waldemar Kafke; Peter Kraft
Journal:  Case Rep Neurol       Date:  2016-06-27

9.  No influence of dabigatran anticoagulation on hemorrhagic transformation in an experimental model of ischemic stroke.

Authors:  Ferdinand Bohmann; Ana Mirceska; Josef Pfeilschifter; Edelgard Lindhoff-Last; Helmuth Steinmetz; Christian Foerch; Waltraud Pfeilschifter
Journal:  PLoS One       Date:  2012-07-24       Impact factor: 3.240

10.  NOACs versus warfarin for stroke prevention in patients with AF: a systematic review and meta-analysis.

Authors:  Tim Hicks; Fiona Stewart; Anne Eisinga
Journal:  Open Heart       Date:  2016-01-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.